Charles Schwab Investment Management Inc. Raises Stock Position in Avantor, Inc. (NYSE:AVTR)

Charles Schwab Investment Management Inc. lifted its position in Avantor, Inc. (NYSE:AVTR - Free Report) by 4.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,952,901 shares of the company's stock after purchasing an additional 121,810 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.43% of Avantor worth $76,392,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Quadrature Capital Ltd lifted its stake in Avantor by 45.3% during the 1st quarter. Quadrature Capital Ltd now owns 18,265 shares of the company's stock valued at $467,000 after acquiring an additional 5,695 shares during the period. Kennedy Capital Management LLC grew its position in Avantor by 50.9% during the 1st quarter. Kennedy Capital Management LLC now owns 79,483 shares of the company's stock worth $2,032,000 after purchasing an additional 26,814 shares during the period. California State Teachers Retirement System raised its stake in shares of Avantor by 0.5% during the 1st quarter. California State Teachers Retirement System now owns 1,067,938 shares of the company's stock valued at $27,307,000 after buying an additional 5,230 shares during the last quarter. Tidal Investments LLC lifted its holdings in shares of Avantor by 19.6% in the 1st quarter. Tidal Investments LLC now owns 14,654 shares of the company's stock valued at $375,000 after buying an additional 2,399 shares during the period. Finally, Swedbank AB purchased a new stake in shares of Avantor in the first quarter worth about $2,707,000. Institutional investors and hedge funds own 95.08% of the company's stock.

Insider Activity

In other news, CAO Steven W. Eck sold 3,525 shares of the business's stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the transaction, the chief accounting officer now directly owns 29,544 shares in the company, valued at $740,372.64. The trade was a 10.66 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 1.30% of the company's stock.

Wall Street Analysts Forecast Growth

AVTR has been the subject of several recent research reports. Royal Bank of Canada reaffirmed an "outperform" rating and set a $34.00 target price on shares of Avantor in a report on Thursday, September 26th. Barclays cut their price objective on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating for the company in a report on Friday, October 25th. Robert W. Baird lowered their target price on shares of Avantor from $27.00 to $26.00 and set an "outperform" rating on the stock in a research note on Monday, October 28th. Wells Fargo & Company cut their price target on Avantor from $30.00 to $28.00 and set an "overweight" rating for the company in a research note on Monday, October 28th. Finally, UBS Group reduced their price target on Avantor from $30.00 to $29.00 and set a "buy" rating for the company in a report on Tuesday, October 8th. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $27.57.

Avantor Price Performance

NYSE AVTR traded up $0.03 during mid-day trading on Thursday, hitting $21.04. The stock had a trading volume of 5,572,413 shares, compared to its average volume of 6,506,209. The firm's 50 day moving average is $23.40 and its 200 day moving average is $23.76. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The stock has a market capitalization of $14.32 billion, a price-to-earnings ratio of 45.74, a PEG ratio of 2.56 and a beta of 1.35. Avantor, Inc. has a twelve month low of $19.59 and a twelve month high of $28.00.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.